CCL2 and osteosarcoma: More importantly, our Affymetrix Gene Chip results also demonstrated that the expression of MCP-1(CCL2) was not significantly changed after TIPE1 transfection, demonstrating that there might be other more important mechanisms involved in TIPE1-mediated osteosarcoma tumorigenesis and progression.